From 1999 to 2018, the proportion of living kidney donors classified as overweight or mildly obese increased, while the proportion of those considered moderately or morbidly obese has decreased, a study found.
Obese men treated with docetaxel for metastatic castration-resistant prostate cancer have longer cancer-specific and overall survival, a study found.
Kidney cancer and some other cancers tied to obesity are increasing the most rapidly among individuals younger than 50.
Study of Korean radical prostatectomy patients showed that those who were obese had significant increased odds of biochemical recurrence and cancer-specific mortality
Obesity is associated with an increased likelihood of clear cell and possibly chromophobe renal cell carcinoma.
The association between obesity, age, and renal cell carcinoma prognosis requires additional investigation.
New study “adds to the evidence of obesity-associated advantages,” researchers conclude.
Obese individuals and those with central obesity have 1.4- and 1.7-fold greater odds of urinary incontinence (UI), respectively, and 1.4- and 1.9-fold greater odds of urge UI.
Findings show MHO is transient, so not a reliable predictor of lower cardiovascular risk in the future
Obese men with non-metastatic castration-resistant prostate cancer have a 21% decreased risk of death compared with normal weight men, according to a study.
